Transactions
2
Insider / MERIT MEDICAL SYSTEMS INC
Ward Lynne N.
Director at MERIT MEDICAL SYSTEMS INC
- Company
- MERIT MEDICAL SYSTEMS INC
- Ticker
- MMSI
- First filing on record
- May 11, 2026
- Latest trade on record
- May 18, 2026
- SEC filings
- EDGAR ↗
Ward Lynne N., Director at MERIT MEDICAL SYSTEMS INC, has disclosed 2 transactions in MMSI since May 11, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $313K at the reported prices. The latest was filed May 19, 2026, 1 day after the trade.
Open-market buys
0
Sales
1
Avg. disclosure lag
2.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Ward Lynne N. made no purchases and 1 sale worth $313K, plus 1 other transaction. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Ward Lynne N. has traded 1 stock on record; the largest by dollars is MMSI.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 3,457 | — |
| S | Open-market sale | 1 | 5,000 | $313K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 0 | 1 · $313K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MMSI | Other A | May 18, 2026 | May 19, 2026 | 1d | 3,457 | — | — | Form 4 ↗ | ||
| MMSI | Sell S | May 7, 2026 | May 11, 2026 | 4d | 5,000 | $63 | $313K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 19, 2026 | Form 4 | 0001786127-26-000004 | 1 | published | EDGAR ↗ |
| May 11, 2026 | Form 4 | 0001786127-26-000002 | 1 | published | EDGAR ↗ |
Other insiders at MERIT MEDICAL SYSTEMS INC
- Peterson Neil W. CHIEF OPERATING OFFICER 8 rows
- Voigt Michel J. CHIEF HUMAN RESOURCES OFFICER 7 rows
- Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY 6 rows
- McDonnell Michael R. Director 6 rows
- Gunderson Thomas J. Director 5 rows
- Parra Raul Jr. CFO AND TREASURER 5 rows
- Smith Christian Adam Chief Commercial Officer 5 rows
- Carpenter Lonny J. Director 4 rows
- Lampropoulos Fred P. Executive Chairman 4 rows
- Aronson Martha Goldberg President and CEO 3 rows
Everyone on file, with contracts and lobbying under the company's name: MERIT MEDICAL SYSTEMS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 2 | May 11, 2026 | May 19, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.